A phase II study of encorafenib and cetuximab (EC) beyond progression in combination with FOLFIRI in

Authors: Maria Alessandra Calegari, Lisa Salvatore, Michele Basso, Maria Laura Iaia, Giulia Caira, Alexia Spring, Giovanni Trovato, Luciana Giannone, Martina Ventola, Antonia Cosmai, Linda Di Francesco, Maria Bensi, Laura Chiofalo, Paola Troisi, Anna Ceccarelli, Giustina Valente, Carmelo Pozzo, Alessandra Anna Anna Prete, Federica Morano, Giampaolo Tortora

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3642

Source: Full article


Abstract

TPS3642